News

AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer
AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...
Study points to promising chemoimmunotherapy strategy for aggressive stage III non-small cell lung cancer
A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery ...
BlackDoctor1d
Your Treatment Options For The Four Stages Of Lung Cancer
Treating stage three lung cancer can include a combination of chemotherapy, surgery, radiation, targeted therapies, and immune therapies. The exact medications and timeline will depend on the exact ...
Frontiers2d
Artificial Intelligence Advancing Lung Cancer Screening and Treatment
Lung cancer is the leading cause of cancer-related mortality globally. Although low-dose computed tomography (LDCT) has shown ...
PharmExec2d
Oncology Care Index Reveals Physician Struggles with Cancer Innovation Pace
Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine explains how insights from the ...
Cancer drug candidate developed using supercomputing and AI blocks tumor growth without toxic side effects
A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...
Medical Dialogues3d
AstraZeneca Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small cell lung cancer
Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...
AZoLifeSciences on MSN3d
Fusion Genes Emerge as Key Drivers in Cancer Development
Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...